Skip to Content

You are here

Cara Westmark Lab

Dr. Westmark’s basic and translational science research in the fields of Alzheimer’s disease and fragile X syndrome focuses on the synaptic function of amyloid beta protein precursor (APP) and amyloid-beta. The goal is to identify therapeutic and dietary approaches that reduce amyloid-beta and rescue seizure, behavioral, cognitive and biomarker phenotypes.